The WACC of India Glycols Ltd (INDIAGLYCO.NS) is 17.3%.
Range | Selected | |
Cost of equity | 17.60% - 20.50% | 19.05% |
Tax rate | 13.00% - 17.70% | 15.35% |
Cost of debt | 8.80% - 18.60% | 13.70% |
WACC | 15.2% - 19.3% | 17.3% |
Category | Low | High |
Long-term bond rate | 6.9% | 7.4% |
Equity market risk premium | 8.3% | 9.3% |
Adjusted beta | 1.29 | 1.36 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 17.60% | 20.50% |
Tax rate | 13.00% | 17.70% |
Debt/Equity ratio | 0.31 | 0.31 |
Cost of debt | 8.80% | 18.60% |
After-tax WACC | 15.2% | 19.3% |
Selected WACC | 17.3% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for INDIAGLYCO.NS:
cost_of_equity (19.05%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (1.29) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.